| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| MSD |
|
microcephaly with spastic diplegia (Paine syndrome)
|
|
|
0.674 |
0.654 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| MIR10A |
|
microRNA 10a
|
|
|
0.513 |
0.846 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR132 |
|
microRNA 132
|
|
|
0.485 |
0.846 |